0001715954-21-000002.txt : 20210310 0001715954-21-000002.hdr.sgml : 20210310 20210310163955 ACCESSION NUMBER: 0001715954-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 EFFECTIVENESS DATE: 20210310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viracta Subsidiary, Inc. CENTRAL INDEX KEY: 0001416377 IRS NUMBER: 260814473 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391789 FILM NUMBER: 21730368 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 700 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584008470 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 700 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Viracta Therapeutics, INC. DATE OF NAME CHANGE: 20170405 FORMER COMPANY: FORMER CONFORMED NAME: HEMAQUEST PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20120321 FORMER COMPANY: FORMER CONFORMED NAME: HEMAQUEST PHARMACEUTICALS DATE OF NAME CHANGE: 20090108 D 1 primary_doc.xml X0708 D LIVE 0001416377 Viracta Subsidiary, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 (858) 771-4190 DELAWARE Viracta Therapeutics, INC. HEMAQUEST PHARMACEUTICALS, INC. HEMAQUEST PHARMACEUTICALS Corporation true Ivor Royston c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Executive Officer Director Richard Ghalie c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Michael Huang c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Samuel Murphy c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Roger Pomerantz c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Gur Roshwalb c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Daniel Chevallard c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Executive Officer Biotechnology Decline to Disclose 06b false 2021-02-24 false true false 0 64999994 64999994 0 false 26 0 0 0 false Viracta Subsidiary, Inc. /s/ Daniel Chevallard Daniel Chevallard Chief Financial Officer and Chief Operating Officer 2021-03-10